Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Sell
10,511
-3,884
-27% -$1.38M 1.25% 20
2025
Q4
$4.71M Sell
14,395
-244
-2% -$77.4K 1.54% 15
2025
Q3
$4.13M Buy
14,639
+175
+1% +$50.8K 1.29% 20
2025
Q2
$4.04M Buy
14,464
+78
+0.5% +$22.1K 1.45% 17
2025
Q1
$4.48M Buy
14,386
+445
+3% +$131K 1.93% 10
2024
Q4
$3.63M Sell
13,941
-14
-0.1% -$4.15K 1.49% 16
2024
Q3
$4.5M Buy
13,955
+341
+3% +$112K 1.98% 10
2024
Q2
$4.25M Sell
13,614
-98
-0.7% -$28.8K 1.97% 11
2024
Q1
$3.82M Buy
13,712
+3,799
+38% +$1.11M 1.81% 13
2023
Q4
$2.85M Sell
9,913
-1,626
-14% -$443K 1.58% 16
2023
Q3
$2.56M Hold
11,539
1.72% 14
2023
Q2
$2.56M Sell
11,539
-251
-2% -$58.2K 1.72% 14
2023
Q1
$2.85M Sell
11,790
-173
-1% -$42.5K 1.68% 12
2022
Q4
$3.14M Buy
11,963
+4,180
+54% +$1.12M 1.79% 12
2022
Q3
$1.75M Buy
7,783
+23
+0.3% +$5.58K 1.11% 32
2022
Q2
$1.89M Sell
7,760
-101
-1% -$24.8K 1.14% 27
2022
Q1
$1.9M Buy
7,861
+21
+0.3% +$4.83K 0.99% 36
2021
Q4
$1.76M Buy
7,840
+1,528
+24% +$322K 0.89% 41
2021
Q3
$1.34M Buy
6,312
+1,743
+38% +$401K 0.69% 51
2021
Q2
$1.11M Buy
4,569
+1,044
+30% +$257K 0.53% 60
2021
Q1
$877K Buy
3,525
+397
+13% +$94.7K 0.41% 68
2020
Q4
$719K Buy
3,128
+173
+6% +$39.9K 0.39% 66
2020
Q3
$751K Buy
2,955
+1,232
+72% +$305K 0.54% 51
2020
Q2
$406K Buy
1,723
+113
+7% +$25.8K 0.29% 62
2020
Q1
$326K Sell
1,610
-359
-18% -$78.4K 0.33% 57
2019
Q4
$475K Buy
1,969
+164
+9% +$36.2K 0.28% 52
2019
Q3
$349K Buy
+1,805
New +$346K 0.22% 51

Other funds holding AMGN

X-Square Capital's AMGN Position: Q1 2026 in Review

X-Square Capital reduced its Amgen (AMGN) stake by 27% in Q1 2026, selling an estimated $1.38M and leaving 10,511 shares worth $3.7M. The position accounts for 1.25% of the portfolio, ranked #20.

X-Square Capital first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. The position peaked at $4.71M in Q4 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • X-Square Capital held 10,511 shares of Amgen worth $3.7M as of Q1 2026.
  • X-Square Capital sold 3,884 Amgen shares in Q1 2026, an estimated $1.38M.
  • Amgen made up 1.25% of X-Square Capital's portfolio in Q1 2026, its #20 holding.
  • X-Square Capital first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
  • X-Square Capital's Amgen position peaked at $4.71M in Q4 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on X-Square Capital's 13F filing for Q1 2026, filed 15 May 2026.